Cellectis S.A. (EPA:ALCLS)
France
· Delayed Price · Currency is EUR 3.160
-0.150 (-4.53%)
At close: Mar 6, 2026
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
€321,270
Profits / Employee
€137,586
Market Cap
239.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Transgene | 147 |
| Genfit | 188 |
| MaaT Pharma | 65 |
| Innate Pharma | 174 |
| Sensorion | 68 |
| Adocia | 77 |
| ABIONYX Pharma | 51 |
| OSE Immunotherapeutics | 64 |
Cellectis News
- 2 days ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 2 months ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 2 months ago - Cellectis (CLLS) Receives New 'Buy' Rating from Clear Street | CLLS Stock News - GuruFocus
- 2 months ago - Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This - Seeking Alpha
- 2 months ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 2 months ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 2 months ago - Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis - GlobeNewsWire
- 2 months ago - Cellectis (CLLS) Arbitration Outcome Adjusts License Agreement - GuruFocus